ArticleOncoTargets and therapy2026

Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.

Jasson Villarreal Hernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.